Boston — As colleges and universities consider strategies for the spring semester to keep COVID-19 cases down, a study conducted by experts in epidemic modeling may help shed light on what mitigation strategies may be most effective, both in terms of infections prevented and cost. Investigators from Brigham and Women’s Hospital, Massachusetts General Hospital and Case Western Reserve University used the Clinical and Economic Analysis of COVID-19 interventions (CEACOV) model to perform their study, finding that combining a mandatory mask-wearing policy with extensive social distancing would prevent 87 percent of infections among students and faculty. Routine testing was also highly effective at preventing infections, but may be cost prohibitive for many colleges and universities. The team also reports that, even if campuses remain closed, there would likely be infections among faculty acquired from the surrounding community, as well as infections among students who return to live off campus in and around college towns. Results are published in Annals of Internal Medicine.
“This next semester represents a critical time in the pandemic. While the vaccine rollout has begun, it is unlikely that most college students will be eligible for the vaccine until late in the spring semester,” said lead author Elena Losina, PhD, Director of the Policy and Innovation eValuations in Orthopedic Treatments (PIVOT) Center at the Brigham. “However, our modeling shows that colleges and universities can put effective programs in place to mitigate infections. This analysis is designed to help individuals and institutions make decisions using a formal, data-driven approach.”
The team evaluated 24 mitigation strategies based on four approaches: social distancing, mask-wearing policies, isolation, and laboratory testing. The team compared results from a minimal social distancing program, in which only large gatherings such as sporting events or concerts were cancelled, and an extensive social distancing program, where all large classes and 50 percent of smaller classes were delivered online. Laboratory testing ranged from no testing of asymptomatic students and faculty to routine testing at 14-, 7-, or 3-day intervals.
The team’s modeling predicted that:
“If colleges put less effort into social distancing and mask-wearing policies, they need to rely more on routine laboratory testing at higher cost to reduce the spread of COVID-19. If less costly tests were available, then routine testing would be feasible in more college settings,” said co-senior author Kenneth A. Freedberg, director of the Medical Practice Evaluation Center at Massachusetts General Hospital and a professor of Medicine at Harvard Medical School.
"This analysis quantifies the value of implementing and committing to mask-wearing and social distancing in college campuses as a key to operating safely during the COVID-19 pandemic," said co-senior author Pooyan Kazemian, PhD, an assistant professor of operations in the Weatherhead School of Management at Case Western Reserve University. "Extensive social distancing in college campuses with a hybrid educational system, combined with a mandatory mask-wearing policy, can prevent the vast majority of COVID-19 cases on college campuses."
While the researchers tried to capture the major COVID-19 mitigation strategies colleges are considering, the study could not examine all strategies and the analysis was restricted to one semester.
“It’s critical to consider the tradeoffs and costs of mitigation efforts and what’s feasible for colleges and universities whose budgets vary widely,” said Losina. “Our analysis showed how colleges can develop strategies to help keep infections at bay. We hope that by the end of next semester, vaccines will be available to many students and faculty. Until then, preventing infections should continue to be the highest priority.”
Funding for this work was provided by the U.S. National Institutes of Health (NIAID 476 R37AI058736-16S1, NIAMS K24AR057827).
Paper cited: Losina, E et al. “College campuses and COVID-19 mitigation: clinical and economic value” Annals of Internal Medicine DOI: 10.7326/M20-6558
Brigham Health, a global leader in creating a healthier world, consists of Brigham and Women's Hospital, Brigham and Women’s Faulkner Hospital, the Brigham and Women’s Physicians Organization and many related facilities and programs. With more than 1,000 inpatient beds, approximately 60,000 inpatient stays and 1.7 million outpatient encounters annually, Brigham Health’s 1,200 physicians provide expert care in virtually every medical and surgical specialty to patients locally, regionally and around the world. An international leader in basic, clinical and translational research, Brigham Health has nearly 5,000 scientists, including physician-investigators, renowned biomedical researchers and faculty supported by over $700 million in funding. The Brigham’s medical preeminence dates back to 1832, and now, with 19,000 employees, that rich history is the foundation for its commitment to research, innovation, and community. Boston-based Brigham and Women’s Hospital is a teaching affiliate of Harvard Medical School and dedicated to educating and training the next generation of health care professionals. For more information, resources, and to follow us on social media, please visit brighamandwomens.org.
